These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2516443)
1. Effects of the natural and unnatural isomers and degradation products of enprostil on gastric acid secretion and gastrointestinal motility in the rat. Rosenkranz RP; Fisher PE; Turke ML; Perry MR; Wong AG; Wren DL; Cooper GF; Smith WL Arzneimittelforschung; 1989 Dec; 39(12):1568-71. PubMed ID: 2516443 [TBL] [Abstract][Full Text] [Related]
2. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester. Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and platelets in vitro. Eglen RM; Whiting RL Br J Pharmacol; 1989 Dec; 98(4):1335-43. PubMed ID: 2514950 [TBL] [Abstract][Full Text] [Related]
4. Effects of enprostil on cardiovascular and respiratory parameters in the dog, and on hematologic parameters in the rat, monkey, and human. Johnson LG; Bruno JJ; Allely MC; Eglen RM; Chang K; Yang D; Alps BJ; Rosenkranz RP; Strosberg AM Arzneimittelforschung; 1989 Nov; 39(11):1443-8. PubMed ID: 2515862 [TBL] [Abstract][Full Text] [Related]
5. Antisecretory effect of a PGE2 derivative, enprostil (TA/RS-84135): inhibitory action of amogastrin-stimulated secretion. Kohli Y; Katoh T; Suzuki K Drugs Exp Clin Res; 1988; 14(11):673-8. PubMed ID: 3149933 [TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal and uterine effects of enprostil. Wong AG; Turke ML; Perry MR; Blissard DD; Faurot G; Hsu S; Ku P; Smith WL Proc West Pharmacol Soc; 1989; 32():41-7. PubMed ID: 2506550 [No Abstract] [Full Text] [Related]
7. Central and peripheral effects of prostaglandin E2 and enprostil on gastric acid secretion in the rat. Sautereau D; Chicau-Chovet M; Tsocas A; Rozé C Eur J Pharmacol; 1991 Mar; 195(2):217-24. PubMed ID: 1678708 [TBL] [Abstract][Full Text] [Related]
9. The gastric antisecretory profile of enprostil. Wong AG; Turke ML; Perry MR; Blissard DD; Waterbury LD; Smith WL Proc West Pharmacol Soc; 1989; 32():49-56. PubMed ID: 2506551 [No Abstract] [Full Text] [Related]
10. Gastrointestinal and cardiovascular effects of the prostaglandin analogue Hoe 260. Bickel M; Bartmann W; Beck G; Lerch U; Schleyerbach R; Schölkens BA Biomed Biochim Acta; 1984; 43(8-9):S235-8. PubMed ID: 6596097 [TBL] [Abstract][Full Text] [Related]
11. Effect of MDL 646, a new synthetic prostaglandin, on gastroesophageal motility of the rat. Coruzzi G; Poli E; Adami M; Bertaccini G; Glässer A Farmaco Sci; 1983 Feb; 38(2):121-7. PubMed ID: 6682381 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and gastric antisecretory properties of allenic 16-phenoxy-omega-tetranor prostaglandin E analogs. Carpio H; Cooper GF; Edwards JA; Fried JH; Garay GL; Guzman A; Mendez JA; Muchowski JM; Roszkowski AP; Van Horn AR Prostaglandins; 1987 Feb; 33(2):169-80. PubMed ID: 3588969 [TBL] [Abstract][Full Text] [Related]
13. Action of MDL 646, a new synthetic prostaglandin, on gastric acid secretion of some experimental animals. Scarpignato C; Spina G; Signorini GC; Bertaccini G Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):211-28. PubMed ID: 6573736 [TBL] [Abstract][Full Text] [Related]
15. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs. Katz LB; Shriver DA; Tobia AJ; Rosenthale ME J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199 [TBL] [Abstract][Full Text] [Related]
16. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats. Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722 [TBL] [Abstract][Full Text] [Related]
17. [Action of a new synthetic prostaglandin on gastroesophageal motility of the rat]. Poli E; Coruzzi G Acta Biomed Ateneo Parmense; 1982; 53(3):117-9. PubMed ID: 6216698 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of 2-guanidinebenzimidazole and 1-phenylbiguanide on gastric acid secretion in rats. Pinelli A; Colombo R; Trivulzio S; Berti F; Tofanetti O; Caimi BR Arzneimittelforschung; 1984; 34(8):890-4. PubMed ID: 6093826 [TBL] [Abstract][Full Text] [Related]
19. Enprostil reduces the increase of gastric corpus mucosal mass induced by the hydrogen-potassium-stimulated adenosine triphosphatase inhibitor BY 831-78 in the rat. Inauen W; Rohner C; Koelz HR; Herdmann J; Schürer-Maly CC; Varga L; Halter F Gastroenterology; 1989 Oct; 97(4):846-52. PubMed ID: 2570729 [TBL] [Abstract][Full Text] [Related]
20. The effects of enprostil and RS-86505-007 on in-vitro intestinal permeability of rabbit and monkey. Grass GM; Sweetana SA; Bozarth CA J Pharm Pharmacol; 1990 Jan; 42(1):40-4. PubMed ID: 1969948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]